Circ_0007444 Inhibits the Progression of Ovarian Cancer via Mediating the miR-570-3p/PTEN Axis

References

• Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics. CA Cancer J Clin. 2018;68:284–296. doi:10.3322/caac.21456
   PubMed Web of Science ®Google Scholar
• Zhang M, Xia B, Xu Y, et al. Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis. Artif Cells Nanomed Biotechnol. 2019;47:1224–1233. doi:10.1080/21691401.2019.1593999
   PubMed Web of Science ®Google Scholar
• Holmes D. Ovarian cancer: beyond resistance. Nature. 2015;527:S217. doi:10.1038/527S217a
   PubMed Web of Science ®Google Scholar
• Guo N, Liu XF, Pant OP, et al. Circular RNAs: novel promising biomarkers in ocular diseases. Int J Med Sci. 2019;16:513–518. doi:10.7150/ijms.29750
   PubMed Web of Science ®Google Scholar
• Li X, Diao H. Circular RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR1 and CDR1. J Cell Physiol. 2019;234:13807–13819. doi:10.1002/jcp.28061
   PubMed Web of Science ®Google Scholar
• Liu L, Yang X, Li NF, et al. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Cell Cycle. 2019;18:2939–2953. doi:10.1080/15384101.2019.1664223
   PubMed Web of Science ®Google Scholar
• Li QH, Liu Y, Chen S, et al. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Biomed Pharmacother. 2019;114:108832. doi:10.1016/j.biopha.2019.108832
   PubMed Web of Science ®Google Scholar
• Pei C, Wang H, Shi C, et al. CircRNA hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial-mesenchymal transition and apoptotic signaling pathways. J Clin Lab Anal. 2020;34:e23292. doi:10.1002/jcla.23292
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou Q, Qiu Q, et al. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer. Mol Cancer. 2019;18:144. doi:10.1186/s12943-019-1080-5
   PubMed Web of Science ®Google Scholar
• Hu J, Wang L, Chen J, et al. The circular RNA circ-ITCH suppresses ovarian carcinoma progression through targeting miR-145/RASA1 signaling. Biochem Biophys Res Commun. 2018;505:222–228. doi:10.1016/j.bbrc.2018.09.060
   PubMed Web of Science ®Google Scholar
• Zhu M, Dang Y, Yang Z, et al. Comprehensive RNA sequencing in adenoma-cancer transition identified predictive biomarkers and therapeutic targets of human CRC. Mol Ther Nucleic Acids. 2020;20:25–33. doi:10.1016/j.omtn.2020.01.031
   PubMedGoogle Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15:995–1005. doi:10.1080/15476286.2018.1486659
   PubMed Web of Science ®Google Scholar
• Xie L, Mao M, Xiong K, et al. Circular RNAs: A novel player in development and disease of the central nervous system. Front Cell Neurosci. 2017;11:354. doi:10.3389/fncel.2017.00354
   PubMed Web of Science ®Google Scholar
• Yang C, Yuan W, Yang X, et al. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Mol Cancer. 2018;17:19. doi:10.1186/s12943-018-0771-7
   PubMed Web of Science ®Google Scholar
• Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2017;14:514–521. doi:10.1080/15476286.2015.1122162
   PubMed Web of Science ®Google Scholar
• Wang LL, Huang WW, Huang J, et al. Protective effect of hsa-miR −570-3p targeting CD274 on triple negative breast cancer by blocking PI3K /AKT/mTOR signaling pathway. Kaohsiung J Med Sci. 2020;36:581–591. doi:10.1002/kjm2.12212
   PubMed Web of Science ®Google Scholar
• Slattery ML, Herrick JS, Mullany LE, et al. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer. 2015;137:428–438. doi:10.1002/ijc.29384
   PubMed Web of Science ®Google Scholar
• He Q, Yan D, Dong W, et al. circRNA circFUT8 upregulates krüpple-like factor 10 to inhibit the metastasis of bladder cancer via sponging miR-570-3p. Mol Ther Oncolytics. 2020;16:172–187. doi:10.1016/j.omto.2019.12.014
   PubMed Web of Science ®Google Scholar
• Bao X, Zhao L, Guan H, et al. Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma. Cell Death Dis. 2018;9:611. doi:10.1038/s41419-018-0620-z
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu A, Feng X, et al. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog Biophys Mol Biol. 2019;148:65–72. doi:10.1016/j.pbiomolbio.2017.09.019
   PubMed Web of Science ®Google Scholar
• Wu Q, Yu S, Chen J, et al. Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level. IUBMB Life. 2018;70:120–128. doi:10.1002/iub.1707
   PubMed Web of Science ®Google Scholar
• Li S, Shen Y, Wang M, et al. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis. Oncotarget. 2017;8:32043–32054. doi:10.18632/oncotarget.16761
   PubMedGoogle Scholar
• Zhao W, Han T, Li B, et al. miR-552 promotes ovarian cancer progression by regulating PTEN pathway. J Ovarian Res. 2019;12:121. doi:10.1186/s13048-019-0589-y
   PubMed Web of Science ®Google Scholar
• Wang J, Xu W, He Y, et al. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN. Inflamm Res. 2018;67:927–936. doi:10.1007/s00011-018-1186-z
   PubMed Web of Science ®Google Scholar
• Liu J, Chen W, Zhang H, et al. miR-214 targets the PTEN-mediated PI3K/Akt signaling pathway and regulates cell proliferation and apoptosis in ovarian cancer. Oncol Lett. 2017;14:5711–5718. doi:10.3892/ol.2017.6953
   PubMed Web of Science ®Google Scholar
• Shen F, Zong ZH, Liu Y, et al. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway. Biomed Pharmacother. 2019;114:108787. doi:10.1016/j.biopha.2019.108787
   PubMed Web of Science ®Google Scholar